Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, et al. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials. Lancet 2024;403:147-159.
PMID: 38008109